United States Software as a Medical Device Market to hit US$ 715 Million by 2033 | Major Players 2026 - Viz.ai, Inc., Medtronic Plc, AliveCor

As per DataM intelligence research report "The US Software as a Medical Device Market reached US$ 205.12 million in 2024 and is expected to reach US$ 715.00 million by 2033, growing at a CAGR of 13.5% during the forecast period 2025-2033."

The market is expanding with rising adoption of software-based healthcare solutions for diagnosis and monitoring. SaMD improves clinical decision-making and patient outcomes. Regulatory support and digital health innovation drive growth.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/us-software-as-a-medical-device-market?prasad

Technological Advancements

✅ Feb 2026 - AI-Driven Diagnostic Algorithms for Clinical Decision Support by GE HealthCare
Advanced AI-powered SaMD solutions are enabling real-time image analysis and predictive diagnostics across radiology and cardiology applications. These platforms improve accuracy, reduce interpretation time, and support clinician decision-making. The innovation is accelerating adoption of AI-based medical software in U.S. healthcare systems.

✅ Jan 2026 - Cloud-Integrated SaMD Platforms for Remote Monitoring by Philips
Cloud-enabled software solutions are enhancing remote patient monitoring and chronic disease management. These platforms allow continuous data tracking, secure sharing, and automated alerts for healthcare providers. The advancement supports value-based care and telehealth expansion in the U.S. market.

✅ Nov 2025 - Interoperable Digital Therapeutics & SaMD Integration by Siemens Healthineers
Companies are integrating SaMD with digital therapeutics and electronic health record systems to ensure seamless data flow and regulatory compliance. These systems improve treatment adherence and patient engagement. The innovation is strengthening ecosystem connectivity across hospitals and clinics.

Product Launches & Innovations

✅ Feb 2026 - Launch of AI-Based Imaging Software Solutions by Aidoc
Medical AI companies are launching FDA-cleared imaging software capable of detecting critical conditions such as stroke and pulmonary embolism. These solutions prioritize urgent cases and reduce diagnostic delays. The launch reflects growing demand for AI-enabled SaMD tools in U.S. healthcare facilities.

✅ Dec 2025 - Introduction of Digital Therapeutic SaMD Applications by Pear Therapeutics
Digital therapeutics integrated with SaMD frameworks are being introduced to treat behavioral health and chronic conditions. These applications provide evidence-based therapy through regulated software platforms. The innovation is expanding non-invasive, software-driven treatment options.

✅ Oct 2025 - Expansion of Cardiac Monitoring Software Platforms by iRhythm Technologies
Companies are enhancing cloud-based cardiac monitoring software that analyzes ECG data using AI algorithms. These platforms improve arrhythmia detection and patient management. The development is driving adoption of software-centric cardiac diagnostics.

Mergers & Acquisitions

✅ Jan 2026 - Strategic Partnerships to Advance AI in SaMD by GE HealthCare
Healthcare technology providers are partnering with AI startups and hospital networks to accelerate SaMD deployment. These collaborations focus on regulatory compliance, data security, and clinical validation. The strategy is strengthening innovation and commercialization in the U.S. SaMD market.

✅ Dec 2025 - Acquisition to Strengthen Digital Health Portfolios by Philips
Philips expanded its digital health ecosystem through acquisitions targeting AI-driven diagnostic and monitoring software. These moves enhance its position in regulated medical software solutions. The acquisition supports long-term growth in the U.S. SaMD segment.

✅ Nov 2025 - Collaborations for Regulatory and Compliance Advancements by Medtronic
Medical device manufacturers are collaborating with regulatory experts and software developers to ensure FDA compliance for SaMD products. These partnerships streamline approval pathways and improve cybersecurity frameworks. The initiative is accelerating safe and compliant innovation in the U.S. market.

US Software as a Medical Device Market: Competitive Intelligence
Viz.ai, Inc., Medtronic Plc, AliveCor, Empatica, Bigfoot Biomedical, Digital Diagnostics Inc., Imagen and Orthogonal among others.

The increasing engagement of companies such as Viz.ai, Inc., Medtronic Plc, AliveCor, Empatica, and Bigfoot Biomedical is driving significant growth in the US Software as a Medical Device (SaMD) Market. These organizations are advancing the adoption of regulatory-compliant software solutions that assist clinicians in diagnostics, remote patient monitoring, and chronic disease management. By leveraging AI, machine learning, and cloud integration, they are enhancing clinical accuracy, improving workflow efficiency, and enabling data-driven decision-making. This report underscores how these companies are strengthening the US Software as a Medical Device Market by supporting safer, more efficient, and scalable healthcare delivery.

Complementing this ecosystem, companies such as Digital Diagnostics Inc., Imagen, and Orthogonal bring specialized capabilities that enhance diagnostic precision, patient engagement, and regulatory alignment within the US Software as a Medical Device Market. Their expertise in AI-driven imaging, clinical workflow integration, and connected device platforms allows healthcare providers to optimize treatment plans and improve patient outcomes. Collectively, these companies create a complementary network where innovation, interoperability, and real-world applicability converge, fostering a competitive landscape that accelerates SaMD adoption across hospitals, clinics, and telehealth platforms. This synergy helps reinforce the market's capacity to deliver measurable clinical and operational value.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/us-software-as-a-medical-device-market?prasad

Segment Covered in the US Software as a Medical Device Market:
By Application
The market is segmented into diagnostics 30%, disease management 25%, treatment monitoring 20%, predictive health analytics 15%, and others 10%, with diagnostics dominating due to increasing adoption of AI-driven tools for early disease detection and clinical decision support. Disease management is growing rapidly with the rising prevalence of chronic conditions and need for continuous monitoring. Treatment monitoring solutions are widely used for tracking patient progress and therapy effectiveness. Predictive health analytics is gaining traction with advancements in data analytics and personalized medicine. Increasing demand for remote patient care and digital health solutions drives segment growth.

By Indication
Indications include diabetes 25%, cardiovascular conditions 20%, mental health 15%, oncology 15%, respiratory conditions 15%, and others 10%, with diabetes leading due to high global prevalence and increasing adoption of digital monitoring solutions. Cardiovascular and respiratory conditions are significant segments driven by chronic disease burden. Mental health applications are rapidly growing with rising awareness and digital therapeutics adoption. Oncology is gaining traction with AI-based diagnostics and treatment support tools. Growing focus on personalized and preventive healthcare fuels demand across all indications.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=us-software-as-a-medical-device-market

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.